Sumitra Remedies, LLC – Trademark Portfolio

Entity Type: 16

Sumitra Remedies, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 2 Nice Classification classes. Currently, 1 trademark is registered and 2 are pending. Notable registered marks include VEDIC JUICES. The owner is based in Somerset, NJ.

4 Colgate Court

Somerset, NJ 08873

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Sumitra Remedies, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

32
Light Beverages (3 filings)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

Frequently Asked Questions

How many trademarks does Sumitra Remedies, LLC have?

Sumitra Remedies, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending, 1 abandoned, 1 cancelled.

What trademark classes does Sumitra Remedies, LLC file in?

Sumitra Remedies, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 32 (Light Beverages). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Sumitra Remedies, LLC's most well-known trademarks?

Sumitra Remedies, LLC's registered trademark portfolio includes well-known marks such as VEDIC JUICES. These are among 1 currently registered trademark in the portfolio.

What is Sumitra Remedies, LLC's trademark registration success rate?

Sumitra Remedies, LLC has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 2 applications are pending review.